Cargando…
Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls
Immune dysfunction has been implicated in the pathophysiology of schizophrenia. Leukocyte migration to the site of inflammation is a fundamental step of immune response which involves P-, E-, and L-selectins. Elevated selectin levels have been reported in un-medicated first-episode patients with sch...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363914/ https://www.ncbi.nlm.nih.gov/pubmed/28334045 http://dx.doi.org/10.1371/journal.pone.0174073 |
_version_ | 1782517232917544960 |
---|---|
author | Mohite, Satyajit Yang, Fang Amin, Pooja A. Zunta-Soares, Giovana Colpo, Gabriela D. Stertz, Laura Sharma, Ajaykumar N. Fries, Gabriel R. Walss-Bass, Consuelo Soares, Jair C. Okusaga, Olaoluwa O. |
author_facet | Mohite, Satyajit Yang, Fang Amin, Pooja A. Zunta-Soares, Giovana Colpo, Gabriela D. Stertz, Laura Sharma, Ajaykumar N. Fries, Gabriel R. Walss-Bass, Consuelo Soares, Jair C. Okusaga, Olaoluwa O. |
author_sort | Mohite, Satyajit |
collection | PubMed |
description | Immune dysfunction has been implicated in the pathophysiology of schizophrenia. Leukocyte migration to the site of inflammation is a fundamental step of immune response which involves P-, E-, and L-selectins. Elevated selectin levels have been reported in un-medicated first-episode patients with schizophrenia but not in medicated patients with multi-episode schizophrenia. We measured fasting plasma soluble P-, E-, and L-selectin in 39 medicated patients with multi-episode schizophrenia and 19 healthy controls. In patients, psychotic symptom severity and cognitive function were assessed with the Positive and Negative Syndrome Scale (PANSS) and the NIH Toolbox Cognitive Test Battery respectively. C-reactive protein (CRP) and Body Mass Index (BMI) were measured in patients and controls. Comparison of selectin levels between patients and controls was done with t-tests and linear regression. Pearson correlation coefficients between plasma selectins and PANSS and cognitive measures were calculated. Geometric mean plasma soluble L-selectin level was lower in patients compared to controls from unadjusted (606.7 ± 1.2 ng/ml vs. 937.7 ± 1.15 ng/ml, p < 0.001) and adjusted analyses (β = 0.59; CI 0.41 to 0.88, p = 0.011). There was a trend towards higher plasma soluble P-selectin in patients compared to controls (90.4 ± 1.2ng/ml vs. 71.8 ± 1.2ng/ml, p = 0.059) in the unadjusted analysis. There was no association between the selectins and psychotic symptoms or cognitive function in the patients. In addition, the selectins were not significantly associated with CRP or BMI. The limitations of this study include small sample size and unavailability of information on medications and blood cell counts. The potential utility of soluble L-selectin as a biomarker of antipsychotic exposure in patients with schizophrenia and the concomitant change in immune response with the use of antipsychotics should be further evaluated. |
format | Online Article Text |
id | pubmed-5363914 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53639142017-04-06 Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls Mohite, Satyajit Yang, Fang Amin, Pooja A. Zunta-Soares, Giovana Colpo, Gabriela D. Stertz, Laura Sharma, Ajaykumar N. Fries, Gabriel R. Walss-Bass, Consuelo Soares, Jair C. Okusaga, Olaoluwa O. PLoS One Research Article Immune dysfunction has been implicated in the pathophysiology of schizophrenia. Leukocyte migration to the site of inflammation is a fundamental step of immune response which involves P-, E-, and L-selectins. Elevated selectin levels have been reported in un-medicated first-episode patients with schizophrenia but not in medicated patients with multi-episode schizophrenia. We measured fasting plasma soluble P-, E-, and L-selectin in 39 medicated patients with multi-episode schizophrenia and 19 healthy controls. In patients, psychotic symptom severity and cognitive function were assessed with the Positive and Negative Syndrome Scale (PANSS) and the NIH Toolbox Cognitive Test Battery respectively. C-reactive protein (CRP) and Body Mass Index (BMI) were measured in patients and controls. Comparison of selectin levels between patients and controls was done with t-tests and linear regression. Pearson correlation coefficients between plasma selectins and PANSS and cognitive measures were calculated. Geometric mean plasma soluble L-selectin level was lower in patients compared to controls from unadjusted (606.7 ± 1.2 ng/ml vs. 937.7 ± 1.15 ng/ml, p < 0.001) and adjusted analyses (β = 0.59; CI 0.41 to 0.88, p = 0.011). There was a trend towards higher plasma soluble P-selectin in patients compared to controls (90.4 ± 1.2ng/ml vs. 71.8 ± 1.2ng/ml, p = 0.059) in the unadjusted analysis. There was no association between the selectins and psychotic symptoms or cognitive function in the patients. In addition, the selectins were not significantly associated with CRP or BMI. The limitations of this study include small sample size and unavailability of information on medications and blood cell counts. The potential utility of soluble L-selectin as a biomarker of antipsychotic exposure in patients with schizophrenia and the concomitant change in immune response with the use of antipsychotics should be further evaluated. Public Library of Science 2017-03-23 /pmc/articles/PMC5363914/ /pubmed/28334045 http://dx.doi.org/10.1371/journal.pone.0174073 Text en © 2017 Mohite et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Mohite, Satyajit Yang, Fang Amin, Pooja A. Zunta-Soares, Giovana Colpo, Gabriela D. Stertz, Laura Sharma, Ajaykumar N. Fries, Gabriel R. Walss-Bass, Consuelo Soares, Jair C. Okusaga, Olaoluwa O. Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls |
title | Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls |
title_full | Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls |
title_fullStr | Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls |
title_full_unstemmed | Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls |
title_short | Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls |
title_sort | plasma soluble l-selectin in medicated patients with schizophrenia and healthy controls |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363914/ https://www.ncbi.nlm.nih.gov/pubmed/28334045 http://dx.doi.org/10.1371/journal.pone.0174073 |
work_keys_str_mv | AT mohitesatyajit plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols AT yangfang plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols AT aminpoojaa plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols AT zuntasoaresgiovana plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols AT colpogabrielad plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols AT stertzlaura plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols AT sharmaajaykumarn plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols AT friesgabrielr plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols AT walssbassconsuelo plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols AT soaresjairc plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols AT okusagaolaoluwao plasmasolublelselectininmedicatedpatientswithschizophreniaandhealthycontrols |